May 16, 2012

An experimental kidney cancer drug made by Pfizer didn't extend the time in which patients survived without their disease worsening when compared with a competing drug, according to results of a late-stage clinical trial released Wednesday.

May 16, 2012

Concern over rising fuel prices has eclipsed unemployment — the leading worry since 2009 — as the No. 1 factor that keeps retailers up at night, according to a study released by BDO USA on Monday, though the current uptick in consumer spending somewhat alleviates that concern.

May 16, 2012

Sam's Club has signed a deal with Triad Retail Media to provide pet care information on its website, Triad said Wednesday.

May 16, 2012

ScriptPro has released a new pharmacy robot that it said would have the smallest footprint of its robotics lineup.


May 16, 2012

For those marketers staying awake at night thinking about new ways to drive category growth, Biotab Nutraceuticals may have happened upon a new opportunity — seasonality in sleep aids.

May 16, 2012

Social media ranks as one of those technologies that has changed the world in many ways, allowing networking across the world, sharing of thoughts and events from people’s lives, embarrassment of public figures and, more recently, even helping to feed political revolutions. 


May 16, 2012

First-quarter earnings at Target exceeded a profit forecast the company increased last month after a strong start to the quarter.

May 16, 2012

It’s been more than 200 years since the first successful test of a vaccine against smallpox, and since then, vaccines have become one of the most important means of preventing and eradicating infectious diseases, ranging from minor ailments like the flu to devastating ones like polio.


May 15, 2012

The American Association of Colleges of Pharmacy and the National Community Pharmacists Association announced the winners of a competition designed to highlight the best practices in medication adherence teaching among the nation's 127 colleges and schools of pharmacy.

May 15, 2012

Specialty pharmacy group purchasing and channel management organization Armada Health Care is moving into a bigger office space, the company said Tuesday.

May 15, 2012

The head of drug maker AstraZeneca will retire next month, the company said.

May 15, 2012

Cardinal Health on Tuesday announced it had agreed to a settlement with the Drug Enforcement Agency that allows the company to bring resolution to ongoing litigation.

May 15, 2012

Cesar is boosting its lineup of canine cuisine to include new bite-sized baked treats.

May 15, 2012

Just days after Coty upped its proposal for Avon, the former has decided to withdraw its offer, citing Avon’s “delay and unwillingness to engage in discussions.”

May 15, 2012

Fuse Science on Tuesday announced that it has picked up distribution for its EnerJel product — a topical energy product targeting fitness fanatics — to 200 south Florida pharmacies through a partnership with GAT Trading.

May 15, 2012

The Global Market Development Center will host its 42nd annual General Merchandise Conference in approximately three weeks in Orlando, Fla., the association announced Monday.

May 15, 2012

GlaxoSmithKline is acquiring the remainder of a privately owned research and development company, GSK said Tuesday.

May 15, 2012

J. M. Smucker, has decreased the list price for many of its packaged coffee products due to sustained declines in green coffee costs.

May 15, 2012

Majestic Drug, a manufacturer of niche oral care and personal care products, has named David Fishman as VP.


May 15, 2012

A former football coach is joining an effort to educate men about the risks of a deadly form of skin cancer.

May 15, 2012

Mountain Dew has partnered with Warner Bros.' "The Dark Knight Rises," which will hit theaters this summer.

May 15, 2012

A weight management products and services provider is bringing its items to retail.

May 15, 2012

Oscar Mayer has introduced a complete line of meat products that is free of artificial preservatives, flavors and colors.

May 15, 2012

Net revenues for Teva rose more than 24% for the first quarter ended March 31, thanks to new drug launches and the company's acquisition of drug maker Cephalon.